MV Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $14.6K | Hold |
77
| – | – | ﹤0.01% | 494 |
|
|
2026
Q1 | $15.2K | Buy |
77
+2
| +3% | +$386 | ﹤0.01% | 478 |
|
|
2025
Q4 | $13.7K | Buy |
75
+16
| +27% | +$2.81K | ﹤0.01% | 485 |
|
|
2025
Q3 | $8.98K | Hold |
59
| – | – | ﹤0.01% | 535 |
|
|
2025
Q2 | $8.18K | Hold |
59
| – | – | ﹤0.01% | 555 |
|
|
2025
Q1 | $8.6K | Hold |
59
| – | – | ﹤0.01% | 540 |
|
|
2024
Q4 | $7.67K | Hold |
59
| – | – | ﹤0.01% | 553 |
|
|
2024
Q3 | $9.12K | Hold |
59
| – | – | ﹤0.01% | 547 |
|
|
2024
Q2 | $9.13K | Buy |
59
+45
| +321% | +$6.77K | ﹤0.01% | 535 |
|
|
2024
Q1 | $1.83K | Hold |
14
| – | – | ﹤0.01% | 664 |
|
|
2023
Q4 | $1.82K | Hold |
14
| – | – | ﹤0.01% | 647 |
|
|
2023
Q3 | $1.83K | Hold |
14
| – | – | ﹤0.01% | 637 |
|
|
2023
Q2 | $1.93K | Hold |
14
| – | – | ﹤0.01% | 638 |
|
|
2023
Q1 | $1.88K | Hold |
14
| – | – | ﹤0.01% | 646 |
|
|
2022
Q4 | $1.83K | Hold |
14
| – | – | ﹤0.01% | 618 |
|
|
2022
Q3 | $1K | Hold |
14
| – | – | ﹤0.01% | 643 |
|
|
2022
Q2 | $2K | Hold |
14
| – | – | ﹤0.01% | 613 |
|
|
2022
Q1 | $2K | Hold |
14
| – | – | ﹤0.01% | 641 |
|
|
2021
Q4 | $2K | Hold |
14
| – | – | ﹤0.01% | 650 |
|
|
2021
Q3 | $2K | Hold |
14
| – | – | ﹤0.01% | 664 |
|
|
2021
Q2 | $2K | Hold |
14
| – | – | ﹤0.01% | 614 |
|
|
2021
Q1 | $1K | Hold |
14
| – | – | ﹤0.01% | 334 |
|
|
2020
Q4 | $1K | Hold |
14
| – | – | ﹤0.01% | 295 |
|
|
2020
Q3 | $1K | Hold |
14
| – | – | ﹤0.01% | 264 |
|
|
2020
Q2 | $1K | Hold |
14
| – | – | ﹤0.01% | 269 |
|
|
2020
Q1 | $1K | Hold |
14
| – | – | ﹤0.01% | 319 |
|
|
2019
Q4 | $1K | Buy |
+14
| New | +$1.32K | ﹤0.01% | 342 |
|
|
2017
Q1 | – | Sell |
-121
| Closed | -$7K | – | 357 |
|
|
2016
Q4 | $7K | Hold |
121
| – | – | ﹤0.01% | 254 |
|
|
2016
Q3 | $8K | Hold |
121
| – | – | ﹤0.01% | 240 |
|
|
2016
Q2 | $7K | Hold |
121
| – | – | ﹤0.01% | 248 |
|
|
2016
Q1 | $7K | Hold |
121
| – | – | ﹤0.01% | 240 |
|
|
2015
Q4 | $8K | Hold |
121
| – | – | ﹤0.01% | 246 |
|
|
2015
Q3 | $8K | Hold |
121
| – | – | ﹤0.01% | 235 |
|
|
2015
Q2 | $8K | Hold |
121
| – | – | ﹤0.01% | 315 |
|
|
2015
Q1 | $8K | Hold |
121
| – | – | ﹤0.01% | 305 |
|
|
2014
Q4 | $9K | Buy |
+121
| New | +$8.66K | ﹤0.01% | 296 |
|
Other funds holding AZN
EP
IA
MV Capital Management's AZN Position: Q2 2026 in Review
MV Capital Management held its AstraZeneca (AZN) position steady in Q2 2026 at 77 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #494.
MV Capital Management first reported a position in AZN in Q4 2014 and has held it in 36 quarters since. The position peaked at $15.2K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- MV Capital Management held 77 shares of AstraZeneca worth $14.6K as of Q2 2026.
- MV Capital Management left its AstraZeneca share count unchanged in Q2 2026.
- AstraZeneca made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #494 holding.
- MV Capital Management first reported a position in AstraZeneca in Q4 2014 and has held it in 36 quarters since.
- MV Capital Management's AstraZeneca position peaked at $15.2K in Q1 2026.
- 1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.